临床肺科杂志
臨床肺科雜誌
림상폐과잡지
JOUNAL OF CLINICAL PULMONARY MEDICINE
2014年
8期
1416-1418
,共3页
沐舒坦%NCPAP%小儿%重症肺炎
沐舒坦%NCPAP%小兒%重癥肺炎
목서탄%NCPAP%소인%중증폐염
mucosolvan%NCPAP%children%severe pneumonia
目的:探讨大剂量沐舒坦联合NCPAP治疗小儿重症肺炎的临床疗效。方法将74例重症肺炎患儿随机分为对照组(n=35)和观察组(n=37),在综合治疗的基础上两组给予NCPAP通气,观察组静脉输注大剂量沐舒坦,30 mg/( k·d),观察两组的临床疗效,临床症状缓解时间,PaO2、PaCO2和OI变化及住院时间。结果观察组的总体有效率为94.59%,明显高于对照组82.86%( P<0.05),观察组的临床症状缓解时间、住院时间、治疗后12 h和24 h的PaO2、PaCO2和OI变化均明显优于对照组(P<0.05)。结论大剂量沐舒坦联合NCPAP治疗小儿重症肺炎的疗效显著,可迅速缓解患儿的临床症状、提高PaO2。
目的:探討大劑量沐舒坦聯閤NCPAP治療小兒重癥肺炎的臨床療效。方法將74例重癥肺炎患兒隨機分為對照組(n=35)和觀察組(n=37),在綜閤治療的基礎上兩組給予NCPAP通氣,觀察組靜脈輸註大劑量沐舒坦,30 mg/( k·d),觀察兩組的臨床療效,臨床癥狀緩解時間,PaO2、PaCO2和OI變化及住院時間。結果觀察組的總體有效率為94.59%,明顯高于對照組82.86%( P<0.05),觀察組的臨床癥狀緩解時間、住院時間、治療後12 h和24 h的PaO2、PaCO2和OI變化均明顯優于對照組(P<0.05)。結論大劑量沐舒坦聯閤NCPAP治療小兒重癥肺炎的療效顯著,可迅速緩解患兒的臨床癥狀、提高PaO2。
목적:탐토대제량목서탄연합NCPAP치료소인중증폐염적림상료효。방법장74례중증폐염환인수궤분위대조조(n=35)화관찰조(n=37),재종합치료적기출상량조급여NCPAP통기,관찰조정맥수주대제량목서탄,30 mg/( k·d),관찰량조적림상료효,림상증상완해시간,PaO2、PaCO2화OI변화급주원시간。결과관찰조적총체유효솔위94.59%,명현고우대조조82.86%( P<0.05),관찰조적림상증상완해시간、주원시간、치료후12 h화24 h적PaO2、PaCO2화OI변화균명현우우대조조(P<0.05)。결론대제량목서탄연합NCPAP치료소인중증폐염적료효현저,가신속완해환인적림상증상、제고PaO2。
Objective To study the clinical effect of large doses of mucosolvan combined with NCPAP in the treatment of children with severe pneumonia. Methods 72 children with severe pneumonia were randomly divided into the control group ( n=35 ) and the observation group ( n=37 ) . All patients were given NCPAP ventilation on the basis of the comprehensive treatment, and the observation group was given large doses of mucosolvan, 30 mg/( k. d) by infusion pump input. The clinical effect, ease time of clinical symptoms, PaO2 , PaCO2 and OI changes, and duration of hospital stay were compared between the two groups. Results The total effective rate of the observation group was 94. 59%, which was significantly higher than 82. 86% of the control group (P<0. 05). The improvement of remission time of clinical symptoms, duration of hospital stay, PaO2 , PaCO2 and OI 12 and 24 hours was more pro-nounced in the observation group than in the control group ( P<0. 05 ) . Conclusion Large doses of mucosolvan combined with NCPAP has significantly clinical effect in the treatment of children with severe pneumonia, which can rapidly relieve the children 's clinical symptoms and improve PaO2 .